Holen Sie sich die Stockscreener-App
14.36
2.57%
0.36
Handel nachbörslich:
13.70
-0.66
-4.60%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$14.00
Offen:
$14.17
24-Stunden-Volumen:
1.86M
Relative Volume:
0.89
Marktkapitalisierung:
$970.30M
Einnahmen:
$796.00M
Nettoeinkommen (Verlust:
$-136.49M
KGV:
-6.8708
EPS:
-2.09
Netto-Cashflow:
$-64.24M
1W Leistung:
-3.88%
1M Leistung:
-2.38%
6M Leistung:
-33.15%
1J Leistung:
-55.00%
1-Tages-Spanne:
$13.69
$14.42
1-Wochen-Bereich:
$13.66
$15.51
52-Wochen-Spanne:
$9.98
$38.28
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Vergleichen Sie TNDM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
14.36 | 945.97M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Fortgesetzt | Stifel | Hold |
| 2025-09-08 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-06-16 | Eingeleitet | Truist | Hold |
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2025-03-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Earnings visualization tools for Tandem Diabetes Care Inc.2025 Price Targets & AI Forecast Swing Trade Picks - newser.com
Chart overlay techniques for tracking Tandem Diabetes Care Inc.July 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Pattern recognition hints at Tandem Diabetes Care Inc. upsideWeekly Risk Report & Risk Controlled Daily Plans - newser.com
What indicators show strength in Tandem Diabetes Care Inc.Earnings Growth Report & Entry Point Strategy Guides - newser.com
Is Tandem Diabetes Care Inc. stock supported by innovation pipelineRisk Management & Verified Technical Signals - newser.com
Why Analysts Are Rethinking the Story Behind Tandem Diabetes Care After Recent Developments - Yahoo Finance
How Tandem Diabetes Care Inc. stock compares to industry benchmarksRate Hike & Verified Chart Pattern Signals - newser.com
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ... - Bluefield Daily Telegraph
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Real time pattern detection on Tandem Diabetes Care Inc. stockSwing Trade & Technical Pattern Based Buy Signals - newser.com
Tandem Diabetes Care (TNDM): Examining the Valuation After a Challenging Year and Recent Rebound - Sahm
Is Tandem Diabetes Care Inc. stock a buy on dipsPortfolio Return Report & Smart Allocation Stock Tips - newser.com
Will Tandem Diabetes Care Inc. (TD5A) stock outperform value peersEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Combining machine learning predictions for Tandem Diabetes Care Inc.Trade Ideas & Real-Time Price Movement Reports - newser.com
Using data models to predict Tandem Diabetes Care Inc. stock movementWeekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
How supply chain issues affect Tandem Diabetes Care Inc. stock2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
Tandem Diabetes Care announces upcoming conference presentations - MarketScreener
Tandem Diabetes Stock Falls on DexCom ForecastMarket Update 2025News and Statistics - IndexBox
Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today - Yahoo Finance
Tandem Diabetes Care Announces Upcoming Conference Presentations - Yahoo Finance
Is Tandem Diabetes Care Inc. (TD5A) stock a contrarian opportunityTrade Exit Summary & Low Risk High Win Rate Picks - newser.com
Can you recover from losses in Tandem Diabetes Care Inc.2025 Retail Activity & Safe Capital Growth Tips - newser.com
Is Tandem Diabetes Care Inc. still worth holding after the dipPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Will Tandem Diabetes Care Inc. stock recover after recent dropJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
Can Tandem Diabetes Care Inc. stock hit analyst price targetsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Why Tandem Diabetes Care Inc. stock is recommended by analystsQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Tandem Diabetes Care Launches t:slim X2 Pump Integration with Abbott FreeStyle Libre 3 Plus Sensor - HIT Consultant
Using R and stats models for Tandem Diabetes Care Inc. forecastingPortfolio Return Report & Stepwise Swing Trade Plans - newser.com
Market Might Still Lack Some Conviction On Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Even After 26% Share Price Boost - simplywall.st
Tandem Rolls Out t:slim X2 Insulin Pump with Abbott’s FreeStyle Libre 3 Plus - Medical Product Outsourcing
t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States - Business Wire
Implantable Insulin Pumps Market Size reached US$ 3.2 Billion - openPR.com
Will Tandem Diabetes Care Inc. (TD5A) stock outperform benchmarksPortfolio Value Summary & Free Verified High Yield Trade Plans - fcp.pa.gov.br
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):